The biocompatibility of mesoporous silicates

Sarah P. Hudson, Robert F. Padera, Robert Langer, Daniel S. Kohane

Research output: Contribution to journalArticlepeer-review

Abstract

Micro- and nano-mesoporous silicate particles are considered potential drug delivery systems because of their ordered pore structures, large surface areas and the ease with which they can be chemically modified. However, few cytotoxicity or biocompatibility studies have been reported, especially when silicates are administered in the quantities necessary to deliver low-potency drugs. The biocompatibility of mesoporous silicates of particle sizes ∼150 nm, ∼800 nm and ∼4 μm and pore sizes of 3 nm, 7 nm and 16 nm, respectively, is examined here. In vitro, mesoporous silicates showed a significant degree of toxicity at high concentrations with mesothelial cells. Following subcutaneous injection of silicates in rats, the amount of residual material decreased progressively over 3 months, with good biocompatibility on histology at all time points. In contrast, intra-peritoneal and intra-venous injections in mice resulted in death or euthanasia. No toxicity was seen with subcutaneous injection of the same particles in mice. Microscopic analysis of the lung tissue of the mice indicated that death may be due to thrombosis. Although local tissue reaction to mesoporous silicates was benign, they caused severe systemic toxicity. This toxicity might be mitigated by modification of the materials.

Original languageEnglish
Pages (from-to)4045-4055
Number of pages11
JournalBiomaterials
Volume29
Issue number30
DOIs
Publication statusPublished - Oct 2008

Keywords

  • Biocompatibility
  • Controlled drug release
  • Drug delivery
  • Mesoporous
  • Silicate

Fingerprint

Dive into the research topics of 'The biocompatibility of mesoporous silicates'. Together they form a unique fingerprint.

Cite this